Back to results
US 2022/0054552 A1Published application
Cellular pharmaceutical product containing quantified doubling level stem cells and a method for producing it
OwnerJackson Tsung-Kui Liuinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical cellular composition containing quantified doubling level nucleated cells and a method for producing it.
Claims3
A pharmaceutical composition which comprises 3×108 nucleated cells, from stem cells rich source, in 3 ml volume, sample tested for doubling potential level and calculated projection of its total cell proliferation potential.
Time for doubling, potential doubling level and potential proliferation cell number are applied in clinical treatment for treatment on set time, effectiveness and duration correlation and estimation.
Dependencies are inferred from the claim text.